以下文章来源于东四十条资本 ，作者蒲凡 东四十条资本 . 聚焦股权投资行业人物、事件、数据、研究、政策解读，提供专业视角和深度洞见 | 创投圈有趣的灵魂 将投中网设为"星标⭐"，第一时间收获最新推送 要有勇气追随你的内心和直觉。 作者丨 蒲凡 来源丨 东四十条资本 多年以后，英雄的孩子长大了，成为了像记忆中父亲那样的男子汉，人们都期待着他能够书写一段属于自己的全新故事，可孩子却忘不了当年父亲战败 时的悲壮。于是在书写自己的传奇之前，他毅然地提枪上马，披上父亲当年的战袍，义无反顾的冲向了那些依旧强大的恶魔。 你可能会觉得，我在写一段武侠故事。但其实，这段文字也很适合用来描写乔布斯父子： 2011 年 10 月 5 日，年仅 56 岁的史蒂夫 · 乔布斯因胰腺癌 溘然长逝，留下无数遗憾；十五年后，他的儿子里德 · 乔布斯决定发起一支总规模超过 2 亿美元的风险投资基金，定向投资医疗领域里的创新项目，尤 其是那些旨在根治癌症的医学创新 。 在接受媒体采访的时候，里德 · 乔布斯毫不掩饰自己的 " 意气用事 " ： " 我从来没有想过成为一名风险投资家。我只是意识到，只有从孵化阶段就参与 一个项目，才能真正意义上推动 ...

Financial Performance Summary - In 2025, the company achieved operating revenue of 2.33 billion RMB, representing a year-on-year growth of 2.0%, with a notable 13.1% increase in the fourth quarter [2] - The company's overseas revenue reached 840 million RMB, up 17.9% year-on-year, accounting for 36% of total revenue, an increase of 5 percentage points from 2024 [2] - Domestic revenue was 1.47 billion RMB, down 5.5% year-on-year, but showed recovery with a 14.5% increase in the fourth quarter [2] Growth Drivers - The growth was primarily driven by accelerated globalization, with localized operations in 18 countries and over 400 product certifications abroad [2] - The company reported significant growth in new industries, with new industry revenue accounting for 48.5% of total revenue, growing by 8.8% year-on-year [3] - The AI-related revenue constituted 15% of total revenue, an increase of 2.5 percentage points from 2024, indicating a strong integration of AI and automation technologies [5] Profitability and Challenges - The net profit attributable to shareholders was 250 million RMB, a decline of 31.6% year-on-year, influenced by external market conditions and strategic investments [5] - The gross profit margin was 46.8%, affected by the ramp-up of new production capacity, with a slight improvement of approximately 0.7 percentage points in the fourth quarter [5] - The company faced challenges such as trade frictions and the need for ongoing investments in globalization and innovation, which impacted profitability [6]

数据来源：天眼查APP 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 北京玄薇生物医疗科技有限公司（简称"玄薇医疗"），是一家聚焦肿瘤精准医疗领域的创新型科技企 业，以"AI赋能精准医疗"为核心定位，以"数据驱动优化肿瘤治疗及临床实践"为核心使命，聚焦肿瘤免 疫治疗毒性反应这一关键痛点，致力于成为国内领先的肿瘤专病数据及智能辅助诊疗服务提供商。 证券之星消息，根据天眼查APP于2月24日公布的信息整理，北京玄薇生物医疗科技有限公司种子轮融 资，融资额未披露，参与投资的机构包括梅花创投。 ...

每经讯，海能技术2月25日发布公告称，根据海能未来技术集团股份有限公司发展战略及经营规划，公 司拟与铭晔管理咨询（上海）有限公司共同出资设立元神生物医疗科技（上海）有限公司，注册地位于 上海市，注册资本为200万元，其中，公司以自有资金出资20万元，持股占比10%；铭晔管理咨询（上 海）有限公司以自有资金出资180万元，持股占比90%。 （记者 曾健辉） 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每日经济新闻 ...

新年开新篇，奋进启新程。 在"十五五"开局之年，全国各地涌动实干热潮，各行各业抢抓开局、聚力攻坚，从科技创新研发到 企业生产一线，从项目建设现场到消费市场前沿，发展的活力持续迸发，为2026年经济发展筑好基、开 好局。 在服务新产业中发展新产业 浙江杭州，在算力与新材料赛道，传化集团旗下新安股份交出了硅基液冷领域技术与商用双突破的 新年答卷。 "我们依托60年有机硅材料研发与工程化经验，成功开发出具备高绝缘性、极低挥发性、优异热稳 定性及环境友好特性的硅基冷却液，完美适配浸没式液冷的严苛要求。"新安股份硅基新材料研究院院 长刘继指着浸没在透明冷却液中的服务器，详细讲解硅基液冷解决方案的细节。 针对数据中心、储能安全、超快充电等不同高热场景，新安股份已形成系列化产品矩阵，覆盖从材 料到系统的全链条，首个硅基浸没液冷商用项目在杭州稳定运行，其在新技术、新场景、新产业领域的 探索步伐还在继续。 眼下，液冷成为算力刚需，硅基材料凭借性能、成本与环保三重优势，成为液冷产业化的核心支 撑，市场空间加速打开，2026年有望迎来液冷产业化放量的关键节点。 "应用场景越多样、需求越细分，发展潜力就越大。"刘继充满信心地说，"今 ...

Core Insights - The "12th Shenzhen-Hong Kong (Qianhai) Talent Cooperation Annual Conference" marked the launch of the "Bay Area Talent Pass" platform and the "Shenzhen-Hong Kong HR Alliance," signaling a new phase in talent integration between Shenzhen and Hong Kong [1][3] - The collaboration aims to create a regional innovation community in the Guangdong-Hong Kong-Macao Greater Bay Area, facilitating talent flow and enhancing international recruitment efforts [1][3] Group 1: Talent Integration Initiatives - The "Bay Area Talent Pass" platform focuses on policy recognition and aims to streamline talent evaluation standards between Shenzhen and Hong Kong, providing visa conveniences for foreign talent [3] - The "Shenzhen-Hong Kong HR Alliance" establishes a market-oriented recruitment network to expand the international talent pool [3] - The "Shenzhen 72-Hour Experience Pass" is a key initiative that allows foreign professionals to explore opportunities in the Greater Bay Area, enhancing the region's attractiveness [2][3] Group 2: Innovation and Collaboration - The "Qianhai Jinmaotou" innovation and financing service platform addresses challenges in investment and financing within the tech sector, promoting the integration of talent, capital, industry, and innovation [4][5] - The collaboration between Hong Kong universities and local enterprises aims to facilitate the transfer of research outcomes and attract more talent to Qianhai [6][7] - The "Bay Area Innovation Broker" model is designed to create a closed loop for research, technology transfer, manufacturing, and market expansion, enhancing the flow of innovation resources [7][8] Group 3: Achievements and Future Outlook - Over 1,100 Hong Kong teams have been incubated in Qianhai, with 44 recognized as national high-tech enterprises, showcasing the success of the talent integration efforts [8] - The ongoing initiatives are expected to strengthen the talent magnetism of Qianhai and support the technological innovation landscape in Shenzhen and the Greater Bay Area [8]

经济观察网 近一周（2026年2月9日至13日），Ping An Biomedical Co., Ltd. (PASW.OQ) 股价波动剧烈， 成为主要关注点。根据内部数据库行情数据，2月9日股价大幅上涨21.82%至0.27美元，成交额达109.61 万美元，换手率17.59%；但随后三个交易日连续回调，2月10日下跌5.22%至0.25美元，2月11日下跌 5.12%至0.24美元，2月12日进一步下跌9.13%至0.22美元；2月13日反弹3.65%至0.23美元。区间振幅高达 30%，累计换手率超50%，显示低流动性放大价格波动。同期所属纺织制造板块微涨0.24%，美股纳斯 达克指数上涨0.39%，个股表现显著独立于板块及大盘。 以上内容基于公开资料整理，不构成投资建议。 ...

以上内容基于公开资料整理，不构成投资建议。 股票近期走势 当日，美国三大股指全线收跌，纳斯达克指数下跌2.03%，标普500指数下跌1.57%，道琼斯指数下跌 1.34%。科技股普遍承压，市场对人工智能可能带来的行业颠覆性影响感到担忧，同时美国成屋销售数 据不佳也加剧了避险情绪，导致资金从风险资产流出。在此背景下，该股当日收盘下跌9.13%，报0.22 美元，振幅为13.42%。 经济观察网根据公开信息，Ping An Biomedical Co.,Ltd.(股票代码：PASW.OQ)在2026年2月12日股价下 跌主要受整体市场环境影响。 ...

Core Viewpoint - The Shanghai International Commercial Court has made significant progress in its first year of operation, handling a total of 2,161 cases with a total amount in dispute exceeding 30 billion yuan by the end of 2025 [3][4]. Group 1: Case Handling and Statistics - The court has resolved 1,743 cases, with a diverse range of parties involved from 56 countries and regions across five continents [3][4]. - The main areas of dispute include international sales contracts, foreign service contracts, foreign contracting disputes, foreign equity transfer disputes, and foreign loan contracts [3][4]. - Specific industries involved in disputes include cross-border investment (131 cases), integrated circuits (120 cases), biomedicine (119 cases), shipping and logistics (73 cases), and enterprises "going global" (65 cases) [3][4]. Group 2: International Judicial Cooperation - The court has prioritized international mutual recognition, handling 30 international judicial assistance cases in 2025, marking a 130% increase year-on-year, with a total amount in dispute of 3.83 billion yuan [4]. - The court has contributed to the construction of international commercial rules, with 13 cases from 2025 included in well-known international databases [4][5]. Group 3: Characteristics of Foreign-related Disputes - Foreign-related business types for enterprises include overseas investments, such as establishing companies or acquiring equity, and undertaking local projects, particularly in "Belt and Road" countries [6]. - Recommendations for enterprises "going global" include resolving disputes through mediation, enhancing compliance systems, and being aware of currency exchange risks [6].

Core Insights - The Shanghai International Commercial Court has processed 2,161 cases and concluded 1,743 cases within its first year, with a total amount in dispute exceeding 30 billion yuan [1] - The court's jurisdiction covers parties from 56 countries and regions, with major dispute areas including international sales contracts, foreign service contracts, and cross-border investment [1][2] - The court has seen a 130% year-on-year increase in international judicial assistance cases, with 30 cases accepted in 2025, involving a total amount of 3.83 billion yuan [2] Group 1 - The Shanghai International Commercial Court aims to promote international recognition through the implementation of international judicial assistance systems [2] - The court has contributed to the construction of international commercial rules, with 13 cases from 2025 included in renowned international databases [2] - The court's annual report includes a list of ten typical cases that reflect the understanding and application of international conventions by frontline judges [2] Group 2 - Characteristics of foreign-related disputes include investments abroad and local business contracts, particularly in Belt and Road countries [3] - Recommendations for companies "going global" include resolving disputes through mediation, enhancing compliance systems, and being aware of currency exchange risks [3] - Companies should establish clear dispute resolution agreements to avoid prolonged arbitration processes, as illustrated by a case involving a share transfer in Cambodia [3]